Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

LAMICTAL

SUPPORTING DATA

Marketing information
Key claims
Prevents depression
Supporting data
Does not destabilize mood
Improves quality of life
Tolerability similar to placebo
No weight gain
13 years of experience
A new approach
Introduce at any phase
Can be used in combination
Country information
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. Pivotal trial - index depressed* Authors: Calabrese JR, et al.; for the Lamictal 605 Study Group. Title: A placebo-controlled... 2. Pivotal trial - index manic* Authors: Bowden CL, et al.; for the Lamictal 606 Study group. Title: A placebo-controlled... 3. Lamotrigine and lithium in bipolar disorder* Authors: Goodwin GM, et al. Title: A pooled analysis of two placebo-controlled 18-month trials... 4. Prevention of depression Authors: Yatham L, et al. Title: Lamotrigine but not lithium prevents or delays depressive... 5. Lamotrigine does not destabilize mood* Authors: Grunze H, et al. Title: Lamotrigine controls bipolar depression without... 6. Lamotrigine safety review* Authors: Bowden CL, et al. Title: Safety and tolerability of lamotrigine for bipolar disorder.... 7. Overview of lamotrigine clinical development Authors: Goldsmith DR, et al. Title: Lamotrigine, a review of its use in bipolar disorder.... 8. Lamotrigine in treatment-refractory bipolar disorder Authors: Calabrese JR, et al. Title: Spectrum of activity of lamotrigine in... 9. Mood-stabilizing properties of lamotrigine Authors: Leadbetter R, et al. Title: Mood-stabilising properties of lamotrigine: A review... 10. Guidelines Strengths:First product indicated to prevent bipolar depression (EU/International)Lamotrigine...